BN Business News
Add your company to Business Communicator →

Business · 08/11/2017Updated: 10/17/2026 · 1 min read

FDA Announces Guidance for Developing Drugs to Treat and Prevent Recurrent Herpes Labialis

Summary

The FDA has released a guidance document to help pharmaceutical companies develop treatments and preventions for recurrent herpes labialis, a condition that affects millions of people worldwide.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →